立華股份(300761.SZ):10月份單月生豬完全成本回落至每公斤16.5元以下
格隆匯11月23日丨立華股份(300761.SZ)近期在接待機構投資者調研時表示,公司目前在江蘇、安徽等區域佈局生豬養殖產能,在蘇南蘇中等核心消費區域採用樓房養豬模式,已建成種豬存欄產能13萬頭,商品豬年產能160萬頭。2023年1-10月,公司出欄商品豬近68萬頭,同比增長超70%,預計全年出欄80萬頭。目前存欄基礎母豬6萬多頭,為明年產能利用率的繼續提升打下了基礎。
隨着養殖成績及產能利用率的提升,10月份單月生豬完全成本回落至每公斤16.5元以下。2024年,公司產能利用率的繼續提升將進一步壓低成本。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.